Vincent Fabien
Glattbrugg, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis.
Journal: Circulation
Published: April 13, 2023
Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial.
Journal: Cardiovascular diabetology
Published: February 27, 2023
Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial.
Journal: European journal of heart failure
Published: April 16, 2022
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial.
Journal: European heart journal
Published: March 21, 2022
Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency.
Journal: European journal of heart failure
Published: January 17, 2022
Responder analysis for improvement in 6-min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency.
Journal: European journal of heart failure
Published: December 10, 2021
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study.
Journal: European heart journal
Published: January 25, 2021
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.
Journal: Lancet (London, England)
Published: October 16, 2020
A Pooled Analysis of Serum Phosphate Measurements and Potential Hypophosphataemia Events in 45 Interventional Trials with Ferric Carboxymaltose.
Journal: Journal of clinical medicine
Published: September 29, 2020
Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure.
Journal: European journal of heart failure
Published: August 29, 2019
Real-world outcomes in hereditary angioedema: first experience from the Icatibant Outcome Survey in the United Kingdom.
Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
Published: August 24, 2017
Triggers and Prodromal Symptoms of Angioedema Attacks in Patients With Hereditary Angioedema.
Journal: Journal of investigational allergology & clinical immunology
Published: December 21, 2016
Last Updated: 09/26/2026